Medicines Formulary

Medicines A–Z

D

Drug name	NICE TAs	Comments
Dobutamine injection		Hospital use only
Docetaxel injection	TA214 - Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancer TA109 - Docetaxel for the adjuvant treatment of early node-positive breast cancer TA101 - Docetaxel for the treatment of hormone-refractory metastatic prostate cancer	Negative TA
Docusate capsules
Docusate liquid
Domperidone SF suspension		For swallowing difficulties only
Domperidone suppositories		Second line - domperidone should not be used by people who have serious underlying heart conditions. It should only be used in the relief of symptoms of nausea and vomiting and at the lowest effective dose for the shortest possible duration. Adults should take no more than three 10mg tablets per day. Domperidone should no longer be used to treat other conditions such as heartburn, bloating or relief of stomach discomfort.
Domperidone suppositories
Domperidone suspension		Second line - domperidone should not be used by people who have serious underlying heart conditions. It should only be used in the relief of symptoms of nausea and vomiting and at the lowest effective dose for the shortest possible duration. Adults should take no more than three 10mg tablets per day. Domperidone should no longer be used to treat other conditions such as heartburn, bloating or relief of stomach discomfort.
Domperidone tablets		Second line - domperidone should not be used by people who have serious underlying heart conditions. It should only be used in the relief of symptoms of nausea and vomiting and at the lowest effective dose for the shortest possible duration. Adults should take no more than three 10mg tablets per day. Domperidone should no longer be used to treat other conditions such as heartburn, bloating or relief of stomach discomfort.
Domperidone tablets		For short term use only

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.